The Role and Efficacy of Coenzyme Q10 in the Management of Erectile Dysfunction in a Hypertensive Male: An Interventional Study.
alpha blocker
b-blocker
coenzyme q10
erectile dysfunction
hypertension
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
accepted:
13
09
2021
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
19
10
2021
Statut:
epublish
Résumé
Introduction Erectile dysfunction (ED) is a prevalent medical condition that affects millions of men globally. A number of pharmacological and complementary options are used in the management of ED, including Coenzyme Q10 (CoQ10). Oxidative stress has been linked to the progression of ED, and Co Q10 protects against oxidative damages and improves erectile function as well as the activity of antioxidant enzymes. This study aimed to determine the efficacy of CoQ10 in the treatment of erectile dysfunction in hypertensive males. Method An open-labeled parallel arm interventional study was conducted in the cardiology unit of Hayatabad Medical Complex Hospital, Peshawar, Pakistan, from March 2020 to March 2021. Hypertensive male patients (n = 230) were randomly allocated to either receiving 200-gram CoQ10 daily along with their current antihypertensive therapy (n=104) or anti-hypertensive treatment only (n=105). The patient's erectile function was assessed at baseline and three months using the International Index of Erectile Function Test (IIEF-5) during the study period. Result Of the total 230, 209 (90.87%) patients were included in the final analysis. There were no significant differences in demographics, history of illness, co-morbid conditions, and current medication of both groups. After three months, 21 (20.1%) participants scored more than 17 in the IIEF-5 and no longer had ED. Overall, no significant difference was found in the mean IIEF-5 score between the study group and control group (14.41 ± 4.49 Vs. 15.61 ± 4.82; p=0.06). However, in subgroup analysis, significant improvement in the study group was seen in participants with mild ED (p=0.03). Conclusion With the demonstration of its efficacy in hypertensive patients with mild ED, co-enzyme Q10 supplementation can be proposed as a potential candidate in patients with long-term hypertension and can play a role in erectile dysfunction.
Identifiants
pubmed: 34660127
doi: 10.7759/cureus.17937
pmc: PMC8513668
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e17937Informations de copyright
Copyright © 2021, Aguilera-Alvarez et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Expert Opin Pharmacother. 2013 Jul;14(10):1333-44
pubmed: 23675780
Asian J Androl. 2006 Mar;8(2):177-82
pubmed: 16491268
Curr Opin Nephrol Hypertens. 2012 Mar;21(2):163-70
pubmed: 22240443
Cochrane Database Syst Rev. 2016 Mar 03;3:CD007435
pubmed: 26935713
Front Physiol. 2018 Feb 05;9:44
pubmed: 29459830
Int J Impot Res. 2002 Aug;14(4):226-44
pubmed: 12152111
BJU Int. 2019 Jul 2;:
pubmed: 31267639
Int J Impot Res. 2010 Sep-Oct;22(5):298-309
pubmed: 20720560
Neural Regen Res. 2019 Feb;14(2):197-200
pubmed: 30530997
J Clin Hypertens (Greenwich). 2006 Apr;8(4):269-74
pubmed: 16596030
Urology. 2006 Mar;67(3):575-8
pubmed: 16527582
J Urol. 1994 Jan;151(1):54-61
pubmed: 8254833
J Am Coll Nutr. 2001 Dec;20(6):591-8
pubmed: 11771674
Urology. 1999 Aug;54(2):346-51
pubmed: 10443736
J Urol. 2000 Oct;164(4):1188-91
pubmed: 10992363
Am J Hypertens. 2005 Mar;18(3):427-30
pubmed: 15797665
Biofactors. 2008;32(1-4):199-208
pubmed: 19096117
Int J Impot Res. 2007 May-Jun;19(3):296-302
pubmed: 17151696
Indian J Urol. 2007 Apr;23(2):109-13
pubmed: 19675783
Curr Cardiol Rev. 2018;14(3):164-174
pubmed: 29663894
Arch Med Sci. 2010 Aug 30;6(4):513-8
pubmed: 22371793
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685